Predicate |
Object |
contentType |
Comparative Study|Journal Article|Research Support, Non-U.S. Gov't |
endingPage |
342 |
issn |
1179-1896 1175-5652 |
issueIdentifier |
5 |
pageRange |
331-342 |
publicationName |
Applied Health Economics and Health Policy |
startingPage |
331 |
bibliographicCitation |
Kourlaba G, Fragoulakis V, Maniadakis N. Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for Greece. Appl Health Econ Health Policy. 2012 Sep 01;10(5):331–42. doi: 10.1007/bf03261867. PMID: 22853743. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daa2cc894cd40ea3dc8bfa31ab49616c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74ea24a4408c815579fce2313f826710 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_715ecde3254c60da41c9cdfb23b5f639 |
date |
2012-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/22853743 https://doi.org/10.1007/bf03261867 |
isPartOf |
https://portal.issn.org/resource/ISSN/1179-1896 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/31719 https://portal.issn.org/resource/ISSN/1175-5652 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/ |
title |
Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for Greece |
discusses |
http://id.nlm.nih.gov/mesh/M0155432 http://id.nlm.nih.gov/mesh/M0021526 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0001864 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11310 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9412 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606 |